Sunday, May 22, 2022

Health

ProHealth Urgent Care’s Staff Receives COVID-19 Vaccine

ProHealth Urgent Care, a medical facility serving patients in St. Croix, continues to take every initiative and precaution during the COVID pandemic to care for the community safely. ProHealth received their allocated Pfizer-BioNTech COVID-19 vaccines at 8:00...

FDA panel meets to decide approval for 2nd COVID-19 vaccine

 Today, the US Food and Drug Administration (FDA) advisory committee is holding a vote on whether to authorize Moderna's coronavirus vaccine in the United States. The approval, if provided today, would make the second coronavirus vaccine available in...

BioBiz: Seattle Cancer Care Alliance receives the recently authorized COVID-19 vaccine; FSD Pharma begins dosing in COVID-19 trials

The Seattle Cancer Care Alliance (SCCA), the only National Comprehensive Cancer Network (NCCN)- member cancer center in Washington state, was selected by the Washington State Department of Health to be one of the first 17 sites to receive the...

CA biotech develops COVID-19 nasal spray which protects up to 10 hours

A small Emeryville, CA biotech firm is developing InvisiMask, a self-administered nasal spray, that protects against SARS-CoV-2 infection, the novel coronavirus that causes COVID-19, for up to 10 hours in early animal studies. The hope would be to...

Pfizer, BioNTech COVID-19 vaccine grabs emergency FDA OK

Just over 24 hours after an FDA advisory panel recommended emergency use of Pfizer and BioNTech’s COVID-19 vaccine, the agency followed through, authorizing the first coronavirus pandemic shot for emergency use in the U.S. The FDA...

Panel votes to recommend FDA approval of Pfizer’s COVID-19 vaccine

Late day Thursday, a government advisory panel gave their nods for the use of Pfizer’s COVID-19 vaccine, allowing for the Food and Drug Administration (FDA) to grant the approval for the vaccine. In a 17-4...

New Biomarker may help determine men at higher risk of developing invasive Prostate Cancer

In a published study, in EBio Medicine, researchers at Arizona-based biotech, Aqualung Therapeutics may have identified a novel biomarker that alone, or potentially combined with Prostate-specific antigen (PSA), may determine men who are at higher risk of...

FDA Authorizes Quest Diagnostics SARS-CoV-2/Flu Test With Self-Collection Kit for Emergency Use

The US Food and Drug Administration on Friday evening granted Emergency Use Authorization for the first time to a diagnostic test for at-home, self-collection of patient samples for the detection of SARS-CoV-2 and influenza A/B.

Study: Women face a higher risk for heart failure and heart attack death than men

According to new research published today in the American Heart Association's flagship journal Circulation, women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with...

Moderna applies for FDA authorization for its Covid-19 vaccine

Moderna today announced that the primary efficacy analysis of their Phase 3 study of their vaccine candidate, mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The data analysis indicates a...
- Advertisement -

Latest News

Elon Musk to Acquire Twitter

Twitter, Inc. made it official, it has entered into a definitive agreement to be acquired by an...
- Advertisement -

Renters of color pay higher security deposits, more application fees

Results from Zillow's Consumer Housing Trends Report show renters of color typically submit more applications — and pay more in application fees — before they secure...

FDA investigating illnesses linked to Lucky Charms

The Food and Drug Administration is now investigating why hundreds of consumers have reported becoming ill after eating Lucky Charms cereal.

Inflation, war push stress to alarming levels at the two-year COVID-19 anniversary

Two years after the World Health Organization declared COVID-19 a global pandemic, inflation, money issues and the war in Ukraine have pushed...

Data published in a Lancet journal on novel COVID-19 vaccine shows it produced robust antibodies and T cells against SARS-CoV-2

A COVID-19 investigational vaccine, developed by City of Hope scientists and now licensed to GeoVax Labs Inc., produced a robust neutralizing antibody...